Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.44 |
| ▸ | FKBP1A | P62942 | 2/20 | 0.42 |
| ▸ | PDE8B | O95263 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | KDM1A | O60341 | 1/20 | 0.39 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | GLA | P06280 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29550642 | 1.00 | ATM (0.44) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL29550830 | 1.00 | ATM (0.44) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL6340488 | 0.93 | ATM (0.42) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL26547634 | 0.93 | ATM (0.42) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL24739379 | 0.93 | ATM (0.48) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL29551182 | 0.93 | ATM (0.48) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL16551790 | 0.89 | ATM (0.47) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL6921210 | 0.89 | ATM (0.47) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL6350025 | 0.89 | ATM (0.47) | ATMFKBP1APDE8BMEN1KMT2A | |
| SCHEMBL702497 | 0.88 | ATM (0.43) | ATMFKBP1APDE8BKDM1ACHEK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8178535-B2 | Substituted sulfonamide compounds having bradykinin 1 receptor activity and use thereof as medicaments | GRUENENTHAL GMBH (DE) | 2012-05-15 | — | — | US | disclosed |
| US-20090203672-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-08-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090203672-A1 | Substituted Sulfonamide Compounds | RPS4X, RPS4Y1, CACNA1A | ATM 2743/4885FKBP1A 855/4885PDE8B 1544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.